SP-0116: Automatic planning strategies  by Heijmen, B.J.M. et al.
3rd ESTRO Forum 2015                                                                                                                                         S55 
 
to identify potential target underdosage for increasing target 
volumes during IMRT to consider adaptive RT.  Tumor 
shrinkage had insignificant dosimetric consequences relative 
to tumour coverage and normal tissue sparing for IMRT 
treatment in this study of 18 patients; 11 growing and 7 
shrinking.   
This lecture will focus on an adaptive study in progress at The 
Princess Margaret which is an extension of the previous study 
to compare a parallel opposed pair technique, conformal 
approach, and IMRT, for 26 patients that required plan 
adaptation for significant TVC during radiotherapy.   Target 
coverage and normal tissue sparing will be compared for the 
shrinking and growing cohorts in order to communicate 
evidence based critical indicators for adaptive IMRT, 
conformal or POP planning for STS patients.  
Adaptive issues and strategies will be discussed for LE-STS 
radiotherapy, using case examples to highlight the different 
considerations and critical thresholds for various RT 
techniques.    
    
SP-0116   
Automatic planning strategies  
B.J.M. Heijmen1, P.W.J. Voet2, M.L.P. Dirkx1, A.W. Sharfo1, 
L. Rossi1, S. Van de Water1, D. Fransen1, J.J. Penninkhof1, 
M.S. Hoogeman1, S.F. Petit1, A.M. Méndez Romero1, J.W. 
Mens1, L. Incrocci1, S. Breedveld1 
1Erasmus MC Cancer Institute, Radiation Oncology, 
Rotterdam, The Netherlands  
2Elekta AB, The Netherlands,  
 
Purpose/Objective: Treatment plans are commonly 
generated by dosimetrists in an iterative trial-and-error 
procedure, aiming at steering the TPS towards an acceptable 
solution. Plan generation may take op to several days of 
workload. Moreover, final plan quality may strongly depend 
on the skills and experience of the dosimetrist, and on 
allotted time. At Erasmus MC, systems for fully automated 
plan generation have been developed to replace the labour-
intensive and operator-dependent trial-and-error approach. 
The core of all systems is “Erasmus-iCycle” (Med Phys. 2012; 
39(2): 951), an in-house optimizer for lexicographic multi-
criterial plan generation. For prostate, head and neck, and 
cervical cancer patients treated at our linacs, automated 
planning is in full clinical use. For Cyberknife (Accuray Inc.) 
and proton therapy, experimental systems are available but 
not yet in routine use. An overview of automated plan 
generation at Erasmus MC will be provided with an accent on 
the clinical application. Applied algorithms will be briefly 
touched. The clinical use and scientific studies on the added 
value of automated planning will be discussed in detail.  
Material/methods:  For each linac patient, the IMRT or VMAT 
treatment plan is automatically generated (no human 
interference) by the clinical TPS (Monaco, Elekta AB), based 
on a patient-specific template. This template is derived 
from a treatment plan that is automatically pre-generated 
with the in-house Erasmus-iCycle optimizer. For individual 
patients of a treatment site (e.g. prostate), automatic plan 
generation in Erasmus-iCycle is based on a fixed ‘wishlist’ 
with hard constraints and treatment objectives with assigned 
priorities. These site-specific wishlists are a priori 
generated in an iterative procedure with wishlist updates in 
every iteration step, based on physicians’ evaluations of 
plans generated with the current wishlist version. In case of 
IMRT, Erasmus-iCycle can be used for integrated beam profile 
optimization and (non-coplanar) beam angle selection. 
Generated Erasmus-iCycle IMRT plans are pareto optimal. 
For Cyberknife treatment, similar systems are being 
developed for both the variable aperture collimator (IRIS) 
and the MLC, using Erasmus-iCycle pre-optimization and final 
plan generation with the clinical TPS (Multiplan, Accuray 
Inc). For intensity-modulated proton therapy (IMPT), 
Erasmus-iCycle has been extended with novel algorithms for 
fast plan generation and plan delivery, saving per patient a 
substantial amount of in-room time compared to plans 
generated with classical optimizers. Novel strategies for 
robust IMPT planning are being explored.  
Results:  In a prospective clinical H&N cancer study, treating 
radiation oncologists selected the Erasmus-iCycle/Monaco 
plan in 97% of cases rather than the plan generated with 
Monaco by trial-and-error (IJROBP 2013; 85(3): 866-72). For a 
group of 44 cervical cancer patients, dual-arc VMAT Erasmus-
iCycle/Monaco plans were superior to plans generated 
manually by an expert cervical cancer planner using Monaco, 
spending many hours; reduced small bowel V15Gy, V45Gy, and 
Dmean, bladder Dmean, and rectum Dmean, all p<0.001. For 30 
prostate cancer patients, differences between Erasmus-
iCycle/Monaco VMAT plans and manual VMAT plans, the latter 
generated by an expert planner with up to 4 hours planning 
hands-on time, were statistically insignificant (IJROBP 2014; 
88(5): 1175-9). All attempts to use automatically generated 
plans as a starting point for manual generation of further 
improved plans have been unsuccessful. 
Conclusion:  Automatic plan generation with consistent high 
plan quality and vast reductions in planning workload is 
feasible. For prostate, head and neck, and cervical cancer 
patients all clinical plans are currently automatically 
generated. For other sites (breast, lung, liver), automated 
planning is being investigated. Use of automated planning for 
Cyberknife and IPMT is being explored.  
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Purpose/Objective: Concern has been raised about the 
extreme dose-fractionation schemes and large biologically 
effective dose used in spinal SBRT because of the greater 
probability of vertebral compression fractures (VCF). 
Prevention of VCF is challenging because the metastatic 
disease lies within the segment at risk. In attempt to reduce 
the risk of VCF, we introduce ‘differential dosing’. MRI 
guidance is used to deliver a high radiation dose to the 
metastasis exclusively. Adjacent healthy appearing bone 
marrow spaces which may possibly contain subclinical disease 
receive the conventional low dose of 8 Gy. Differential dosing 
has the potential advantage of lowering the risk of VCF by 
sparing the unaffected, healthy bone tissue surrounding the 
metastasis while also treating the subclinical disease. In this 
work, the technique used to create differential dosing 
treatment plans and the accuracy of dose delivery are 
presented. 
Materials and Methods: VMAT plans were created for 10 
spinal metastatic patients using Monaco (Elekta, Sweden) 
treatment planning system. Two 10MV photon beam partial 
arcs were employed. Doses of 18 Gy to the metastasis (PTVb) 
and 8 Gy to the surrounding bony compartment (PTVe) were 
prescribed in one fraction. A maximum dose of 25.2Gy and a 
mean dose in the range 17-19Gy were allowed to PTVb. 
Treatment plans were optimized according to the following 
priority list: spinal cord dose constraint (V10<0.35cc), PTVb 
coverage, PTVb mean dose, PTVe dose gradient, PTVe 
